| Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen SE Lupold, BJ Hicke, Y Lin, DS Coffey Cancer research 62 (14), 4029-4033, 2002 | 815 | 2002 |
| Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. K Forrester, S Ambs, SE Lupold, RB Kapust, EA Spillare, WC Weinberg, ... Proceedings of the National Academy of Sciences 93 (6), 2442-2447, 1996 | 558 | 1996 |
| miR-21: an androgen receptor–regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth J Ribas, X Ni, M Haffner, EA Wentzel, AH Salmasi, WH Chowdhury, ... Cancer research 69 (18), 7165-7169, 2009 | 488 | 2009 |
| p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis SP Hussain, P Amstad, P He, A Robles, S Lupold, I Kaneko, M Ichimiya, ... Cancer research 64 (7), 2350-2356, 2004 | 463 | 2004 |
| Nucleic acid aptamers: clinical applications and promising new horizons X Ni, M Castanares, A Mukherjee, SE Lupold Current medicinal chemistry 18 (27), 4206-4214, 2011 | 437 | 2011 |
| The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. XW Wang, W Vermeulen, JD Coursen, M Gibson, SE Lupold, K Forrester, ... Genes & development 10 (10), 1219-1232, 1996 | 434 | 1996 |
| Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) SR Banerjee, CA Foss, M Castanares, RC Mease, Y Byun, JJ Fox, ... Journal of medicinal chemistry 51 (15), 4504-4517, 2008 | 332 | 2008 |
| Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer Y Chen, CA Foss, Y Byun, S Nimmagadda, M Pullambhatla, JJ Fox, ... Journal of medicinal chemistry 51 (24), 7933-7943, 2008 | 278 | 2008 |
| The transcriptional regulation of miR-21, its multiple transcripts and their implication in prostate cancer J Ribas, SE Lupold Cell cycle 9 (5), 923-929, 2010 | 196 | 2010 |
| Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts X Ni, Y Zhang, J Ribas, WH Chowdhury, M Castanares, Z Zhang, M Laiho, ... The Journal of clinical investigation 121 (6), 2383-2390, 2011 | 176 | 2011 |
| Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, CA Foss, ... Angewandte Chemie (International ed. in English) 50 (39), 9167, 2011 | 160 | 2011 |
| Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. K Forrester, SE Lupold, VL Ott, CH Chay, V Band, XW Wang, CC Harris Oncogene 10 (11), 2103-2111, 1995 | 130 | 1995 |
| A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts J Ribas, X Ni, M Castanares, MM Liu, D Esopi, S Yegnasubramanian, ... Nucleic acids research 40 (14), 6821-6833, 2012 | 111 | 2012 |
| A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation K Hatano, B Kumar, Y Zhang, JB Coulter, M Hedayati, B Mears, X Ni, ... Nucleic acids research 43 (8), 4075-4086, 2015 | 94 | 2015 |
| Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening B Kumar, S Khaleghzadegan, B Mears, K Hatano, TA Kudrolli, ... Oncotarget 7 (45), 72593, 2016 | 75 | 2016 |
| Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer CE Fletcher, E Sulpice, S Combe, A Shibakawa, DA Leach, MP Hamilton, ... Oncogene 38 (28), 5700-5724, 2019 | 65 | 2019 |
| Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy N Höti, W Chowdhury, JT Hsieh, MD Sachs, SE Lupold, R Rodriguez Molecular Therapy 14 (6), 768-778, 2006 | 65 | 2006 |
| Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells CL Chen, J Sung, M Cohen, WH Chowdhury, MD Sachs, Y Li, ... Journal of Pharmacology and Experimental Therapeutics 319 (2), 533-542, 2006 | 62 | 2006 |
| Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer BP Neuman, JB Eifler, M Castanares, WH Chowdhury, Y Chen, ... Clinical Cancer Research 21 (4), 771-780, 2015 | 61 | 2015 |
| Investigation of miR‐21, miR‐141, and miR‐221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy Q Zheng, SB Peskoe, J Ribas, F Rafiqi, T Kudrolli, AK Meeker, ... The Prostate 74 (16), 1655-1662, 2014 | 60 | 2014 |
